← Open Payments lookup

JOHN NGUYEN: Open Payments

NPI 1558924803 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,027 in 62 payments from 14 companies in 2025. Trend: 2023 $1,746 · 2024 $2,561 · 2025 $2,027

Food & beverage: $2,027
CompanyPaymentsAmount
Alkermes, Inc.10$361
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$268
Janssen Pharmaceuticals, Inc4$205
Vanda Pharmaceuticals Inc.3$196
ABBVIE INC.10$185
Collegium Pharmaceutical, Inc.2$144
Teva Pharmaceuticals USA, Inc.1$118
Neurocrine BioSciences, Inc.5$117
Axsome Therapeutics, Inc.4$99
Otsuka America Pharmaceutical, Inc.4$98

Products named: CAPLYTA, ARISTADA, INVEGA SUSTENNA, VRAYLAR, FANAPT, Jornay PM, LYBALVI, REXULTI.

Industry payments across CA — which companies pay providers there.